Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus
JAMAPublished 4 November 1998
Marcia A. Testa, Donald C. Simonson
Citations417
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Improved glycemic control of type 2 DM is associated with substantial short-term symptomatic, QOL, and health economic benefits.
Abstract
Improved glycemic control of type 2 DM is associated with substantial short-term symptomatic, QOL, and health economic benefits.
Keywords
Medicine
New England Journal of MedicineThe Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
24,537 Citations1993David M. Nathan
Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
New England Journal of MedicineThe Effects of Antihypertensive Therapy on the Quality of Life
1,343 Citations1986Sydney H. Croog, Sol Levine +6 more
It is shown that antihypertensive agents have different effects on the quality of life and that these can be meaningfully assessed with available psychosocial measures.
Medical CareComparative Measurement Sensitivity of Short and Longer Health Status Instruments
500 Citations1992Jeffrey N. Katz, Martin G. Larson +3 more
The brief health status measures were equally or more responsive than the SIP after total hip arthroplasty in the physical and global dimensions and had the highest SRM on the psychological dimension.
Diabetes CareSymptoms and Well-Being in Relation to Glycemic Control in Type II Diabetes
264 Citations1996Ferdinand E E Van Der Does, J. N. D. de Neeling +5 more
It is suggested that better glycemic control in type II diabetes is associated with fewer physical symptoms, better mood, and better well-being, in a nonhypoglycemic HbA1c range.
DiabetesIatrogenic Hypoglycemia as a Cause of Hypoglycemia-Associated Autonomic Failure in IDDM: A Vicious Cycle
221 Citations1992Philip E. Cryer
Hypoglycemia-associated autonomic failure in IDDM, a disorder distinct from classical diabetic autonomic neuropathy, is proposed, with the following hypothesis concerning one potential pathogenetic mechanism.
Medical CareThe Relationship Between Glycemic Control and Health-Related Quality of Life in Patients With Non-Insulin-Dependent Diabetes Mellitus
198 Citations1994Morris Weinberger, M. Sue Kirkman +5 more
Unless patients perceive a benefit from following complex diabetic regimens, good glycemic control may continue to be an elusive therapeutic goal, especially in patients with long-standing disease.
Annual Review of Public HealthMethods for Quality-Of-Life Studies
165 Citations1994Marcia A. Testa, Johanna F. Nackley
Since quality-of-life research often involves inferential statistics and hypothesis testing, the statistical and epidemiologic principles of good study design should be followed and one should account for the reliability, responsiveness, and the sensitivity of the scale when designing the scientific hypotheses.
The American Journal of MedicineCognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia
117 Citations1995Matthew T. Draelos, Alan M. Jacobson +5 more
Cognitive function in IDDM patients was generally well-preserved even at substantially elevated blood glucose levels, and women with IDDM were less cognitively impaired than men with ID DM during hypoglycemia.
DiabetesHypoglycemia in IDDM
108 Citations1989Philip E. Cryer, Christian Binder +5 more
Fundamentally, pending the prevention or cure of IDDM, the authors must learn to deliver insulin in a much more physiological fashion or to prevent, correct, or compensate for compromised glucose counterregulation if they are to achieve euglycemia safely in most patients with IDDM.
Journal of the American Society of NephrologyCost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus.
86 Citations1992J E Siegel, Andrzej S. Królewski +2 more
The preliminary analysis suggests that the early treatment of insulin-dependent diabetes mellitus patients with ACEI is likely to be a very cost-effective use of health care resources and compares favorably with those of other medical life-saving interventions.
The American Journal of MedicineBlood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus
58 Citations1995Katie Weinger, Alan M. Jacobson +3 more
Since the majority of patients made clinically serious errors in glucose estimation, and many used symptoms that did not discriminate hyperglycemia and hypoglycemia, individualized training to increase awareness of glucose-related symptoms and glucose levels may help patients reduce the frequency or severity of hyperglycemic and Hypoglycemic events.
Diabetes CareThe DCCT and Medical Care for Diabetes in the U. S.
39 Citations1994Maureen I Harris, Richard C. Eastman +1 more
Intensive treatment of insulin-dependent diabetes mellitus can substantially reduce the incidence and progression of retinopathy, nephropathy, and neuropathy.
PubMedMeasuring quality of life in hypertensive patients with diabetes.
33 Citations1988M A Testa, D C Simonson
A preliminary pilot study consisting of 58 volunteers including healthy normals, patients with diabetes and patients with hypertension indicated that the instrument was practical for the clinic setting and that the scales and composite scores obtained from individual item responses were internally consistent and reliable over repeated trials.